Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RADIOIMMUNOTHERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 905 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nordoy, T; Kolstad, A; Tuck, MK; Aaberge, IS; Husebekk, A; Kaminski, MS
      Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens

      CLINICAL IMMUNOLOGY
    2. Edwards, WB; Reichert, DE; d'Avignon, DA; Welch, MJ
      beta-cyclodextrin dimers as potential tumor pretargeting agents

      CHEMICAL COMMUNICATIONS
    3. Johnson, PWM
      The therapeutic use of antibodies for malignancy

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    4. Wun, T; Kwon, DS; Tuscano, JM
      Radioimmunotherapy - Potential as a therapeutic strategy in non-Hodgkin's lymphoma

      BIODRUGS
    5. McQuarrie, SA; Xiao, Z; Miller, GG; Mercer, JR; Suresh, MR
      Modern trends in radioimmunotherapy of cancer: pretargeting strategies forthe treatment of ovarian cancer

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    6. Gruaz-Guyon, A; Janevik-Ivanovska, E; Raguin, O; De Labriolle-Vaylet, C; Barbet, J
      Radiolabeled bivalent haptens for tumor immunodetection and radioimmunotherapy

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    7. Wittel, UA; Goel, A; Varshney, GC; Batra, SK
      Mucin antibodies - New tools in diagnosis and therapy of cancer

      FRONTIERS IN BIOSCIENCE
    8. Meredith, RF; Alvarez, RD; Partridge, EE; Khazaeli, MB; Lin, CY; Macey, DJ; Austin, JM; Kilgore, LC; Grizzle, WE; Schlom, J; LoBuglio, AF
      Intraperitoneal radioimmunochemotherapy of ovarian cancer: A phase I study

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    9. Kroger, LA; DeNardo, GL; Gumerlock, PH; Xiong, CY; Winthrop, MD; Shi, XB; Mack, PC; Leshchinsky, T; DeNardo, SJ
      Apoptosis-related gene and protein expression in human lymphoma xenografts(Raji) after low dose rate radiation using Cu-67-2IT-BAT-Lym-1 radioimmunotherapy

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    10. Imam, SK
      Status of radioimmunotherapy in the new millennium

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    11. Goshorn, S; Sanderson, J; Axworthy, D; Lin, YK; Hylarides, M; Schultz, J
      Preclinical evaluation of a humanized NR-LU-10 antibody-streptavidin fusion protein for pretargeted cancer therapy

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    12. Milenic, DE; Roselli, M; Mirzadeh, S; Pippin, CG; Gansow, OA; Colcher, D; Brechbiel, MW; Schlom, J
      In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    13. Ochakovskaya, R; Osorio, L; Goldenberg, DM; Mattes, MJ
      Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium

      CLINICAL CANCER RESEARCH
    14. Gutowski, M; Carcenac, M; Pourquier, D; Larroque, C; Saint-Aubert, B; Rouanet, P; Pelegrin, A
      Intraoperative immunophotodetection for radical resection of cancers: Evaluation in an experimental model

      CLINICAL CANCER RESEARCH
    15. Blumenthal, RD; Waskewich, C; Goldenberg, DM; Lew, W; Flefleh, C; Burton, J
      Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts

      CLINICAL CANCER RESEARCH
    16. Cardillo, TM; Ying, ZL; Gold, DV
      Therapeutic advantage of (90)Yttrium-versus (131)Iodine-labeled PAM4 antibody in experimental pancreatic cancer

      CLINICAL CANCER RESEARCH
    17. Ong, GL; Elsamra, SE; Goldenberg, DM; Mattes, MJ
      Single-cell cytotoxicity with radiolabeled antibodies

      CLINICAL CANCER RESEARCH
    18. Dillman, RO
      Monoclonal antibody therapy for lymphoma - An update

      CANCER PRACTICE
    19. Colnot, DR; Quak, JJ; Roos, JC; de Bree, R; Wilhelm, AJ; Snow, GB; van Dongen, GAMS
      Radioimmunotherapy in patients with head and neck squamous cell carcinoma:Initial experience

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    20. Wen, XX; Wu, QP; Lu, Y; Fan, Z; Charnsangavej, C; Wallace, S; Chow, D; Li, C
      Poly(ethylene glycol)-conjugated anti-EGF receptor antibody C225 with radiometal chelator attached to the termini of polymer chains

      BIOCONJUGATE CHEMISTRY
    21. Wilbur, DS; Hamlin, DK; Chyan, MK; Kegley, BB; Pathare, PM
      Biotin reagents for antibody pretargeting. 5. Additional studies of biotinconjugate design to provide biotinidase stability

      BIOCONJUGATE CHEMISTRY
    22. Hylarides, MD; Mallett, RW; Meyer, DL
      A robust method for the preparation and purification of antibody/streptavidin conjugates

      BIOCONJUGATE CHEMISTRY
    23. Tsai, SW; Li, L; Williams, LE; Anderson, AL; Raubitschek, A; Shively, JE
      Metabolism and renal clearance of In-111-labeled DOTA-conjugated antibody fragments

      BIOCONJUGATE CHEMISTRY
    24. Weiden, PL; Breitz, HB
      Pretargeted radioimmunotherapy (PRIT (TM)) for treatment of non-Hodgkin's lymphoma (NHL)

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    25. Allen, BJ; Rizvi, S; Li, Y; Tian, Z; Ranson, M
      In vitro and preclinical targeted alpha therapy for melanoma, breast, prostate and colorectal cancers

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    26. Gold, DV; Cardillo, T; Goldenberg, DM; Sharkey, RM
      Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    27. Burke, PA; DeNardo, SJ
      Antiangiogenic agents and their promising potential in combined therapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    28. Stein, R; Govindan, SV; Chen, S; Reed, L; Spiegelman, H; Griffiths, GL; Hansen, HJ; Goldenberg, DM
      Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodine

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    29. Wiseman, GA; White, CA; Sparks, RB; Erwin, WD; Podoloff, DA; Lamonica, D; Bartlett, NL; Parker, JA; Dunn, WL; Spies, SM; Belanger, R; Witzig, TE; Leigh, BR
      Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin (TM) radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    30. Goldenberg, DM
      The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    31. DeNardo, GL; Juweid, ME; White, CA; Wiseman, GA; DeNardo, SJ
      Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    32. Kashmiri, SVS; Iwahashi, M; Tamura, M; Padlan, EA; Milenic, DE; Schlom, J
      Development of a minimally immunogenic variant of humanized anti-carcinomamonoclonal antibody CC49

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    33. Richman, CM; Denardo, SJ
      Systemic radiotherapy in metastatic breast cancer using Y-90-linked monoclonal MUC-1 antibodies

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    34. Jurcic, JG
      Antibody therapy for residual disease in acute myelogenous leukemia

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    35. Foulon, CF; Welsh, PC; Bigner, DD; Zalutsky, MR
      Positively charged templates for labeling internalizing antibodies: comparison of N-succinimidyl 5-Iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR

      NUCLEAR MEDICINE AND BIOLOGY
    36. Schuhmacher, J; Klivenyi, G; Kaul, S; Henze, M; Matys, R; Hauser, H; Clorius, J
      Pretargeting of human mammary carcinoma xenografts with bispecific anti-MUC1/anti-Ga chelate antibodies and immunoscintigraphy with PET

      NUCLEAR MEDICINE AND BIOLOGY
    37. Yordanov, AT; Garmestani, K; Zhang, M; Zhang, Z; Yao, Z; Phillips, KE; Herring, B; Horak, E; Beitzel, MP; Schwarz, UP; Gansow, OA; Plascjak, PS; Eckelman, WC; Waldmann, TA; Brechbiel, MW
      Preparation and in vivo evaluation of linkers for At-211 labeling of humanized anti-Tac

      NUCLEAR MEDICINE AND BIOLOGY
    38. Garmestani, K; Yao, Z; Zhang, M; Wong, K; Park, CW; Pastan, I; Carrasquillo, JA; Brechbiel, MW
      Synthesis and evaluation of a macrocyclic bifunctional chelating agent foruse with bismuth radionuclides

      NUCLEAR MEDICINE AND BIOLOGY
    39. Hassfjell, S; Ingebrigtsen, K; Bruland, OS
      Synthesis, purification and biodistribution of (205)-Bi-DOTMP, visualizingbone deposition patterns with autoradiography

      NUCLEAR MEDICINE AND BIOLOGY
    40. Lindencrona, U; Nilsson, M; Forssell-Aronsson, E
      Similarities and differences between free At-211 and I-125(-) transport inporcine thyroid epithelial cells cultured in bicameral chambers

      NUCLEAR MEDICINE AND BIOLOGY
    41. Ma, DH; McDevitt, MR; Finn, RD; Scheinberg, DA
      Breakthrough of Ac-225 and its radionuclide daughters from an Ac-225/Bi-213 generator: development of new methods, quantitative characterization, andimplications for clinical use

      APPLIED RADIATION AND ISOTOPES
    42. Hassfjell, S
      A Pb-212 generator based on a Th-228 source

      APPLIED RADIATION AND ISOTOPES
    43. Ma, DH; McDevitt, MR; Finn, RD; Scheinberg, DA
      Rapid preparation of short-lived alpha particle emitting radioimmunopharmaceuticals

      APPLIED RADIATION AND ISOTOPES
    44. Hohn, A; Nortier, FM; Scholten, B; van der Walt, TN; Coenen, HH; Qaim, SM
      Excitation functions of Te-125(p, xn)-reactions from their respective thresholds up to 100 MeV with special reference to the production of I-124

      APPLIED RADIATION AND ISOTOPES
    45. Lindegren, S; Back, T; Jensen, HJ
      Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields

      APPLIED RADIATION AND ISOTOPES
    46. Zimmerman, BE; Unterweger, MP; Brodack, JW
      The standardization of Lu-177 by 4 pi ss liquid scintillation spectrometrywith H-3-standard efficiency tracing

      APPLIED RADIATION AND ISOTOPES
    47. Iznaga-Escobar, N
      Direct radiolabeling of monoclonal antibodies with rhenium-188 for radioimmunotherapy of solid tumors - a review of radiolabeling characteristics, quality control and in vitro stability studies

      APPLIED RADIATION AND ISOTOPES
    48. Moll, JR; Ruvinov, SB; Pastan, I; Vinson, C
      Designed heterodimerizing leucine zippers with a range of pIs and stabilities up to 10(-15) M

      PROTEIN SCIENCE
    49. Saga, T; Sakahara, H; Nakamoto, Y; Sato, N; Ishimori, T; Mamede, M; Kobayashi, H; Masunaga, S; Sasai, K; Kuroki, M; Konishi, J
      Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia

      EUROPEAN JOURNAL OF CANCER
    50. Maloney, DG
      Mechanism of action of rituximab

      ANTI-CANCER DRUGS
    51. Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Dearling, J; Bhatia, J; Begent, RHJ
      Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    52. Renner, C; Hartmann, F; Pfreundschuh, M
      The future of monoclonal antibody engineering

      ANNALS OF HEMATOLOGY
    53. Wrasidlo, W; Mysels, KJ
      Generation of lead-212 and radioimmunoconjugates for use in cancer therapyand the 'emanating power' of stearates

      COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
    54. Kinuya, S; Yokoyama, K; Kobayashi, K; Motoishi, S; Onoma, K; Watanabe, N; Shuke, N; Bunko, H; Michigishi, T; Tonami, N
      Experimental radioimmunotherapy with Re-186-MAG3-A7 anti-colorectal cancermonoclonal antibody: Comparison with I-131-counterpart

      ANNALS OF NUCLEAR MEDICINE
    55. Thierens, HM; Monsieurs, MA; Brans, B; Van Driessche, T; Christiaens, I; Dierckx, RA
      Dosimetry from organ to cellular dimensions

      COMPUTERIZED MEDICAL IMAGING AND GRAPHICS
    56. Vose, JM
      Immunotherapy for non-Hodgkin's lymphoma

      ONCOLOGY-NEW YORK
    57. Goodwin, DA; Meares, CF
      Advances in pretargeting biotechnology

      BIOTECHNOLOGY ADVANCES
    58. Cheson, BD
      Some like it hot!

      JOURNAL OF CLINICAL ONCOLOGY
    59. Kaminski, MS; Zelenetz, AD; Press, OW; Saleh, M; Leonard, J; Fehrenbacher, L; Lister, TA; Stagg, RJ; Tidmarsh, GF; Kroll, S; Wahl, RL; Knox, SJ; Vose, JM
      Pivotal study of iodine I 131 Tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas

      JOURNAL OF CLINICAL ONCOLOGY
    60. Wang, RF; Zhang, CL; Yu, LZ; Guo, YF; Bai, Y
      Radiochemical synthesis and preliminary evaluation of anti-bladder cancer monoclonal antibody BDI-1 labeled with rhenium-188

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    61. Wilder, RB; Jones, D; Tucker, SL; Fuller, LM; Ha, CS; McLaughlin, P; Hess, MA; Cabanillas, F; Cox, JD
      Long-term results with radiotherapy for stage I-II follicular lymphomas

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    62. Imam, SK
      Advancements in cancer therapy with alpha-emitters: A review

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    63. Witzig, TE
      Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    64. Flynn, AA; Boxer, GM; Begent, RHJ; Pedley, RB
      Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    65. Turatti, F; Mezzanzanica, D; Nardini, E; Luison, E; Maffioli, L; Bombardieri, E; de Lalla, C; Canevari, S; Figini, M
      Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    66. Kinuya, S; Kawashima, A; Yokoyama, K; Kudo, M; Kasahara, Y; Watanabe, N; Shuke, N; Bunko, H; Michigishi, T; Tonami, N
      Anti-angiogenic therapy and radioimmunotherapy in colon cancer xenografts

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    67. Behr, TM; Behe, M; Jungclas, H; Jungclas, H; Becker, W; Sgouros, G
      Higher relative biological efficiency of alpha-particles: in vitro veritas, in vivo vanitas?

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    68. Reske, SN; Bunjes, D; Buchmann, I; Seitz, U; Glatting, G; Neumaier, B; Kotzerke, J; Buck, A; Martin, H; Dohner, H; Bergmann, L
      Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    69. Behr, TM
      Higher relative biological efficiency of alpha-particles: in vitro veritas, in vivo vanitas?

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    70. Kinuya, S; Yokoyama, K; Konishi, S; Li, XF; Watanabe, N; Shuke, N; Takayama, T; Bunko, H; Michigishi, T; Tonami, N
      Improved response of colon cancer xenografts to radioimmunotherapy with pentoxifylline treatment

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    71. Demartis, S; Tarli, L; Borsi, L; Zardi, L; Neri, D
      Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    72. Diehl, M; Risse, JH; Brandt-Mainz, K; Dietlein, M; Bohuslavizki, KH; Matheja, P; Lange, H; Bredow, J; Korber, C; Grunwald, F
      Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    73. Postema, EJ; Boerman, OC; Oyen, WJG; Raemaekers, JMM; Corstens, FHM
      Radioimmunotherapy of B-cell non-Hodgkin's lymphoma

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    74. Rydh, A; Ahlstrom, KR; Widmark, A; Johansson, L; Nilsson, S; Bergh, A; Damber, JE; Stigbrand, T; Hietala, SO
      Radioimmunoscintigraphy using an anti-prostate monoclonal antibody (E4): adosimetric evaluation

      UROLOGICAL RESEARCH
    75. Bernhardt, P; Forssell-Aronsson, E; Jacobsson, L; Skarnemark, G
      Low-energy electron emitters for targeted radiotherapy of small tumours

      ACTA ONCOLOGICA
    76. Syrigos, KN; Pliarchopoulou, K; Harrington, KJ
      The development of monoclonal antibody therapy in leukemias

      HYBRIDOMA
    77. Goel, A; Batra, SK
      Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer

      TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    78. Andersson, H; Palm, S; Lindegren, S; Back, T; Jacobsson, L; Leser, G; Horvath, G
      Comparision of the therapeutic efficacy of At-211- and I-131-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer

      ANTICANCER RESEARCH
    79. DeNardo, GL; DeNardo, SJ; Kukis, DL; O'Donnell, RT; Shen, S; Mirick, GR; Meares, CF
      Metabolite production in patients with lymphoma after radiometal-labeled antibody administration

      JOURNAL OF NUCLEAR MEDICINE
    80. Colnot, DR; Wilhelm, AJ; Cloos, J; Roos, JC; de Bree, R; Quak, JJ; Snow, GB; van Dongen, GAMS
      Evaluation of limited blood sampling in a preceding Tc-99m-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of Re-186-cMAb U36 radioimmunotherapy

      JOURNAL OF NUCLEAR MEDICINE
    81. Boerman, OC; van Eerd, J; Oyen, WJG; Corstens, FHM
      A 3-step pretargeting strategy to image infection

      JOURNAL OF NUCLEAR MEDICINE
    82. Hamacher, KA; Den, RB; Den, EI; Sgouros, G
      Cellular dose conversion factors for alpha-particle-emitting radionuclidesof interest in radionuclide therapy

      JOURNAL OF NUCLEAR MEDICINE
    83. Barendswaard, EC; Humm, JL; O'Donoghue, JA; Sgouros, G; Finn, RD; Scott, AM; Larson, SM; Welt, S
      Relative therapeutic efficacy of I-125- and I-131-labeled monoclonal antibody A33 in a human colon cancer xenograft

      JOURNAL OF NUCLEAR MEDICINE
    84. Lovqvist, A; Humm, JL; Sheikh, A; Finn, RD; Koziorowski, J; Ruan, S; Pentlow, KS; Jungbluth, A; Welt, S; Lee, FT; Brechbiel, MW; Larson, SM
      PET imaging of Y-86-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: Comparison between Y-86 and In-111 radiolabels

      JOURNAL OF NUCLEAR MEDICINE
    85. Rutar, FJ; Augustine, SC; Colcher, D; Siegel, JA; Jacobson, DA; Tempero, MA; Dukat, VJ; Hohenstein, MA; Gobar, LS; Vose, JM
      Outpatient treatment with I-131-anti-B1 antibody: Radiation exposure to family members

      JOURNAL OF NUCLEAR MEDICINE
    86. Stein, R; Govindan, SV; Chen, S; Reed, L; Richel, H; Griffiths, GL; Hansen, HJ; Goldenberg, DM
      Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: Evaluation of Lu-177 and comparison of its efficacy with that of Y-90 and residualizing I-131

      JOURNAL OF NUCLEAR MEDICINE
    87. Murray, A; Simms, MS; Scholfield, DP; Vincent, RM; Denton, G; Bishop, MC; Price, MR; Perkins, AC
      Production and characterization of Re-188-C595 antibody for radioimmunotherapy of transitional cell bladder cancer

      JOURNAL OF NUCLEAR MEDICINE
    88. Lee, FT; Hall, C; Rigopoulos, A; Zweit, J; Pathmaraj, K; O'Keefe, GJ; Smyth, FE; Welt, S; Old, LJ; Scott, AM
      Immune-PET of human colon xenograft-bearing BALB/c nude mice using I-124-CDR-grafted humanized A33 monoclonal antibody

      JOURNAL OF NUCLEAR MEDICINE
    89. Kinuya, S; Yokoyama, K; Kudo, M; Kasahara, Y; Kobayashi, K; Motoishi, S; Onoma, K; Bunko, H; Michigishi, T; Tonami, N
      Methylxanthine sensitization of human colon cancer cells to Re-186-labeledmonoclonal antibody

      JOURNAL OF NUCLEAR MEDICINE
    90. Yoriyaz, H; Stabin, MG; dos Santos, A
      Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry

      JOURNAL OF NUCLEAR MEDICINE
    91. Lubic, SP; Goodwin, DA; Meares, CF; Song, C; Osen, M; Hays, M
      Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma

      JOURNAL OF NUCLEAR MEDICINE
    92. Visser, GW; Klok, RP; Gebbinck, JWK; ter Linden, T; van Dongen, GA; Molthoff, CF
      Optimal quality I-131-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN

      JOURNAL OF NUCLEAR MEDICINE
    93. Zalutsky, MR; Zhao, XG; Alston, KL; Bigner, D
      High-level production of alpha-particle-emitting At-211 and preparation ofAt-211-Labeled antibodies for clinical use

      JOURNAL OF NUCLEAR MEDICINE
    94. Yao, ZS; Garmestani, K; Wong, KJ; Park, LS; Dadachova, E; Yordanov, A; Waldmann, TA; Eckelman, WC; Paik, CH; Carrasquillo, JA
      Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody

      JOURNAL OF NUCLEAR MEDICINE
    95. Gestin, JF; Loussouarn, A; Bardies, M; Gautherot, E; Gruaz-Guyon, A; Sai-Maurel, C; Barbet, J; Curtet, C; Chatal, JF; Faivre-Chauvet, A
      Two-step targeting of xenografted colon carcinoma using a bispecific antibody and Re-188-labeled bivalent hapten: Biodistribution and dosimetry studies

      JOURNAL OF NUCLEAR MEDICINE
    96. Lenarczyk, M; Goddu, SM; Rao, DV; Howell, RW
      Biologic dosimetry of bone marrow: Induction of micronuclei in reticulocytes after exposure to P-32 and Y-90

      JOURNAL OF NUCLEAR MEDICINE
    97. Erwin, WD; Spies, SM; Kelly, ME; Rao, P; Eckersberg-Rhodes, TE; Nannapaneni, M; Groch, MW
      Correlation of marrow dose estimates based on serial pretreatment radiopharmaceutical imaging and blood data with actual marrow toxicity in anti-CD20yttrium-90 monoclonal antibody radioimmunotherapy of non-Hodgkin's B-cell lymphoma

      NUCLEAR MEDICINE COMMUNICATIONS
    98. Jokisch, DW; Patton, PV; Rajon, DA; Inglis, BA; Bolch, WE
      Chord distributions across 3D digital images of a human thoracic vertebra

      MEDICAL PHYSICS
    99. Lu, XQ; Humm, JL; Chin, LM
      Estimate of absorbed dose based on two-dimensional autoradiographic information in internal radionuclide therapy

      MEDICAL PHYSICS
    100. Barker, SD; Casado, E; Gomez-Navarro, J; Xiang, J; Arafat, W; Mahasreshti, P; Pustilnik, TB; Hemminki, A; Siegal, GP; Alvarez, RD; Curiel, DT
      An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites

      GYNECOLOGIC ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/11/20 alle ore 16:30:11